Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 319 followers
Latest posts
Last updated about 4 hours ago
Human medicines European public assessment report (EPAR): Ztalmy, ganaxolone, Date of authorisation: 26/07/2023, Revision: 6, Status: Authorised
about 4 hours ago
Human medicines European public assessment report (EPAR): Ztalmy, ganaxolone, Date of authorisation...
Human medicines European public assessment report (EPAR): Epidyolex, cannabidiol, Date of authorisation: 19/09/2019, Revision: 20, Status: Authorised
about 4 hours ago
Human medicines European public assessment report (EPAR): Epidyolex, cannabidiol, Date of authorisation...
Human medicines European public assessment report (EPAR): Jeraygo, aprocitentan, Revision: 3, Status: Authorised
about 5 hours ago
Human medicines European public assessment report (EPAR): Jeraygo, aprocitentan, Revision: 3, Status...
Meeting of the HMA-EMA group focused on AI with industry stakeholders - February 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 4 February 2026, 10:00 (CET) to 4 February 2026, 11:30 (CET)
about 5 hours ago
Meeting of the HMA-EMA group focused on AI with industry stakeholders -...
Human medicines European public assessment report (EPAR): Zyprexa, olanzapine, Date of authorisation: 27/09/1996, Revision: 47, Status: Authorised
about 5 hours ago
Human medicines European public assessment report (EPAR): Zyprexa, olanzapine, Date of authorisation...
Quality Innovation Group (QIG): Listen and learn focus group meeting on sustainability, Online, European Medicines Agency, Amsterdam, the Netherlands, from 4 March 2026 to 5 March 2026
about 5 hours ago
Quality Innovation Group (QIG): Listen and learn focus group meeting on sustainability...
Human medicines European public assessment report (EPAR): Aumseqa, Aumolertinib, Date of authorisation: 12/02/2026, Status: Authorised
about 5 hours ago
Human medicines European public assessment report (EPAR): Aumseqa, Aumolertinib, Date of authorisation...
EMA multi-stakeholder workshop on supporting innovation in cardiovascular medicines and medical devices in the EU, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 1 July 2026, 13:00 (CEST) to 2 July 2026, 16:00 (CEST)
about 5 hours ago
EMA multi-stakeholder workshop on supporting innovation in cardiovascular medicines and medical devices...
Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mRNA vaccine, Date of authorisation: 21/12/2020, Revision: 57, Status: Authorised
about 6 hours ago
Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mRNA vaccine, Date...
Human medicines European public assessment report (EPAR): Nustendi, bempedoic acid,ezetimibe, Date of authorisation: 27/03/2020, Revision: 9, Status: Authorised
about 6 hours ago
Human medicines European public assessment report (EPAR): Nustendi, bempedoic acid,ezetimibe, Date of...